Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Argos Therapeutics- Inc. (ARGS)

0.1888 0.014 (7.89%)

06-22 15:59

Open:

0.17

Pre. Close:

0.175

High:

0.1888

Low:

0.168

Volume:

20,934

Market Cap:

2M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.19 - 0.191

0.191 - 0.192

Low:

0.168 - 0.169

0.169 - 0.17

Close:

0.189 - 0.19

0.19 - 0.191

Technical analysis  (as of: 2018-06-22 4:28:23 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 0.22     One year: 0.26

Support:

Support1: 0.17    Support2: 0.15

Resistance:

Resistance1: 0.19    Resistance2: 0.22

Pivot:

0.17

Moving Averages:

MA(5): 0.18     MA(20): 0.17

MA(100): 0.78     MA(250): 2.71

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.04

%K %D:

%K(14,3): 70.70     %D(3): 62.40

RSI:

RSI(14): 44.32

52-Week:

High: 9.4  Low: 0.15  Change(%): -97.5

Average Vol(K):

3-Month: 44454  10-Days 2041

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ARGS has closed above the upper band by 9.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 94.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to ARGS's normal range. The bands have been in this narrow range for 31 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-23T06:42:56-04:00
Biotech Analysis Central Pharma News: Biogen's Deal, Eli Lilly Partner Incyte Refile Baricitinib, Argos Loses Out

2018-04-22T10:44:44-04:00
3 Things In Biotech, April 21: Solid Stands, Argos Stops, NewLink Strives

2018-04-20T08:00:00-04:00
Your Daily Pharma Scoop: Adamas Update, Shire Bidding War, Novartis Results

2018-04-19T12:40:25-04:00
Midday Gainers / Losers (04/19/2018)

2018-04-19T09:24:36-04:00
Premarket Losers as of 9:05 am (04/19/2018)

2018-04-19T09:04:21-04:00
Argos Therapeutics bails on late-stage study of Rocapuldencel-T in kidney cancer; shares down 64%

2018-04-02T08:34:41-04:00
Argos Therapeutics reports Q4 results

2018-02-15T09:21:15-05:00
Premarket Gainers as of 9:05 am (02/15/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

7.91

Shares Float (M)

6.37

% Held by Insiders

% Held by Institutions

0.10

Shares Short (K)

649

Shares Short Prior Month (K)

5590

Stock Financials

EPS

EPS Est. Current Year

-1.190

EPS Est. Next Year

-0.480

EPS Est. Next Quarter

-0.200

Forward EPS

1.#IO

Book Value (p.s.)

2.880

PEG Ratio

Profit Margin

Operating Margin

-1681.58

Return on Assets (ttm)

-61.6

Return on Equity (ttm)

3695.6

Qtrly Rev. Growth

921.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-35.42

Levered Free Cash Flow (M)

-30.86

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

0.07

P/S

3173638.25

P/CF

-0.04

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2018-01-19

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.